115 related articles for article (PubMed ID: 11318801)
1. Evaluation of a global screening assay for the investigation of the protein C anticoagulant pathway.
Rimmer JE; Cooper PC; Brookfield CJ; Preston FE; Makris M
Clin Lab Haematol; 2000 Dec; 22(6):351-4. PubMed ID: 11318801
[TBL] [Abstract][Full Text] [Related]
2. Modification of the ProC Global assay using dilution of patient plasma in factor V-depleted plasma as a screening assay for factor V Leiden mutation.
Quincampoix JC; Legarff M; Rittling C; Andiva S; Toulon P
Blood Coagul Fibrinolysis; 2001 Oct; 12(7):569-76. PubMed ID: 11685046
[TBL] [Abstract][Full Text] [Related]
3. The impact of oral anticoagulant therapy, factor VIII level and quality of factor V-deficient plasma on three commercial methods for activated protein C resistance.
Chitolie A; Lawrie AS; Mackie IJ; Harrison P; Machin SJ
Blood Coagul Fibrinolysis; 2001 Apr; 12(3):179-86. PubMed ID: 11414631
[TBL] [Abstract][Full Text] [Related]
4. Screening for abnormalities of the protein C anticoagulant pathway using the ProC Global assay. Results of a European multicenter evaluation.
Toulon P; Halbmeyer WM; Hafner G; Schmitt Y; Randgard B; Odpadlik M; Van Den Eynden C; Wagner C
Blood Coagul Fibrinolysis; 2000 Jul; 11(5):447-54. PubMed ID: 10937806
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of a new screening assay ProC Global for identification of defects in the protein C/protein S anticoagulant pathway.
Ruzicka K; Kapiotis S; Quehenberger P; Handler S; Pabinger-Fasching I; Mannhalter C; Jilma B; Speiser W
Thromb Res; 1997 Sep; 87(6):501-10. PubMed ID: 9330432
[TBL] [Abstract][Full Text] [Related]
6. [Clinical usefulness of global assays of the anticoagulant pathway of protein C].
Toulon P
Ann Biol Clin (Paris); 2001; 59(5):545-50. PubMed ID: 11602384
[TBL] [Abstract][Full Text] [Related]
7. Screening for risk factors for thrombosis using a new generation of assays developed to evaluate the functionality of the protein C anticoagulant pathway.
Toulon P; Perez P
Hematol Oncol Clin North Am; 2000 Apr; 14(2):379-89. PubMed ID: 10806561
[TBL] [Abstract][Full Text] [Related]
8. A new assay based on thrombin generation inhibition to detect both protein C and protein S deficiencies in plasma.
Duchemin J; Pittet JL; Tartary M; Béguin S; Gaussem P; Alhenc-Gelas M; Aiach M
Thromb Haemost; 1994 Mar; 71(3):331-8. PubMed ID: 8029798
[TBL] [Abstract][Full Text] [Related]
9. The effect of lupus anticoagulant in the second-generation assay for activated protein C resistance.
Ragland BD; Reed CE; Eiland BM; Tichenor PH; Hudson CL; Fritsma GA; Adler BK; Marques MB
Am J Clin Pathol; 2003 Jan; 119(1):66-71. PubMed ID: 12520699
[TBL] [Abstract][Full Text] [Related]
10. ProC Global assay in the evaluation of women with history of severe preeclampsia or HELLP syndrome.
Heilmann L; von Tempelhoff GF; Pollow K
Clin Appl Thromb Hemost; 2002 Oct; 8(4):319-24. PubMed ID: 12518722
[TBL] [Abstract][Full Text] [Related]
11. Screening for identified and unidentified protein C pathway defects by the Agkistrodon contortrix venom test in consecutive patients.
Robert A; Aillaud MF; Eschwège V; Verdy E; Barthet MC; Morange PE; Juhan-Vague I
Am J Clin Pathol; 1999 Aug; 112(2):233-7. PubMed ID: 10439804
[TBL] [Abstract][Full Text] [Related]
12. Haemostatic changes and acquired activated protein C resistance in normal pregnancy.
Mahieu B; Jacobs N; Mahieu S; Naelaerts K; Vertessen F; Weyler J; Jacquemyn Y; Van der Planken M
Blood Coagul Fibrinolysis; 2007 Oct; 18(7):685-8. PubMed ID: 17890957
[TBL] [Abstract][Full Text] [Related]
13. A protein C pathway (PCP) screening test for the detection of APC resistance and protein C or S deficiencies.
Haas FJ; van Sterkenburg-Kamp BM; Scheepers HA
Semin Thromb Hemost; 1998; 24(4):355-62. PubMed ID: 9763352
[TBL] [Abstract][Full Text] [Related]
14. A modified functional global test to measure protein C, protein S activities and the activated protein C-resistance phenotype.
Gemmati D; Serino ML; Scapoli GL
Thromb Res; 1998 Nov; 92(3):141-8. PubMed ID: 9806366
[TBL] [Abstract][Full Text] [Related]
15. "ProC Global": a functional screening test that predicts recurrent venous thromboembolism.
Grand'Maison A; Bates SM; Johnston M; McRae S; Ginsberg JS
Thromb Haemost; 2005 Mar; 93(3):600-4. PubMed ID: 15735816
[TBL] [Abstract][Full Text] [Related]
16. A highly specific functional test for factor V leiden: A modified tissue factor assay for activated protein C resistance.
Arkel YS; Ku D; Kamiyama M; Pajaro R; Alder H; Marchand A
Haemostasis; 1997; 27(6):290-304. PubMed ID: 9731110
[TBL] [Abstract][Full Text] [Related]
17. ProC Global: the first functional screening assay for the complete protein C pathway.
Dati F; Hafner G; Erbes H; Prellwitz W; Kraus M; Niemann F; Noah M; Wagner C
Clin Chem; 1997 Sep; 43(9):1719-23. PubMed ID: 9299966
[TBL] [Abstract][Full Text] [Related]
18. A new dilution for the modified APTT-based assay for activated protein C resistance: improvement of the reliability in patients with a lupus anticoagulant.
Benattar N; Schved JF; Biron-Andréani C
Thromb Haemost; 2000 Jun; 83(6):967-8. PubMed ID: 10896260
[No Abstract] [Full Text] [Related]
19. Validation and standardization of the ETP-based activated protein C resistance test for the clinical investigation of steroid contraceptives in women: an unmet clinical and regulatory need.
Douxfils J; Morimont L; Delvigne AS; Devel P; Masereel B; Haguet H; Bouvy C; Dogné JM
Clin Chem Lab Med; 2020 Jan; 58(2):294-305. PubMed ID: 31444961
[TBL] [Abstract][Full Text] [Related]
20. The activated seven lupus anticoagulant assay detects clinically significant antibodies.
Moore GW; Rangarajan S; Savidge GF
Clin Appl Thromb Hemost; 2008 Jul; 14(3):332-7. PubMed ID: 17895508
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
